On-site genetic testing for prostate cancer increases patient compliance
Dec 27, 2022
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7%.
FDA clears new insulin pump and algorithm-based software
May 25, 2023
The enhanced automatic insulin delivery system was cleared for people with type 1 diabetes aged ≥6 years.
Body mass index, obesity up during the pandemic for U.S. adults
Apr 04, 2022
Higher rates of alcohol consumption and lower smoking rates may have contributed to higher obesity.
Recent cancer may increase risk for Guillain-Barré syndrome
Mar 04, 2022
“It is important that people with cancer know the overall risk of developing Guillain-Barré is still very small,” an author said in a statement.
Preexisting type 2 diabetes tied to later stage of cancer diagnosis
Dec 02, 2022
An increased risk was seen for nonscreenable cancers.
Prostate cancer screening declined following 2012 USPSTF guidance
Dec 22, 2021
In addition, the rates of metastatic disease increased across all races, but particularly among Black men.
Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
Gender life expectancy gap increased from 2010 to 2021
Nov 13, 2023
The leading contributors to the widening gender life expectancy gap from 2019 to 2021 included COVID-19 and unintentional injuries.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.